tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TSE:TLT Stock Latest News

Theralase Expands US Bladder Cancer Study Sites
Company AnnouncementsTheralase Expands US Bladder Cancer Study Sites
13d ago
Theralase Expands Clinical Trial for Bladder Cancer
PremiumCompany Announcements
Theralase Expands Clinical Trial for Bladder Cancer
17d ago
Theralase Expands Cancer Study with Promising Results
PremiumCompany Announcements
Theralase Expands Cancer Study with Promising Results
17d ago
Theralase Reports Revenue Drop Amid Financial Struggles
PremiumCompany Announcements
Theralase Reports Revenue Drop Amid Financial Struggles
25d ago
TLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
TLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
Theralase Technologies Raises Funds for Cancer Research
PremiumCompany AnnouncementsTheralase Technologies Raises Funds for Cancer Research
1M ago
Theralase Technologies Extends Warrant Expiry Date
Premium
Company Announcements
Theralase Technologies Extends Warrant Expiry Date
1M ago
Theralase Achieves Milestone in Bladder Cancer Study
Premium
Company Announcements
Theralase Achieves Milestone in Bladder Cancer Study
3M ago
Theralase Completes Funding Round and Issues Stock Options
PremiumCompany Announcements
Theralase Completes Funding Round and Issues Stock Options
3M ago
Theralase Plans Extension of Share Purchase Warrants
PremiumCompany Announcements
Theralase Plans Extension of Share Purchase Warrants
3M ago
Theralase’s Ruvidar Outshines Acyclovir in Herpes Treatment
PremiumCompany Announcements
Theralase’s Ruvidar Outshines Acyclovir in Herpes Treatment
4M ago
Theralase’s Rutherrin® Boosts Lung Cancer Chemotherapy
PremiumCompany Announcements
Theralase’s Rutherrin® Boosts Lung Cancer Chemotherapy
4M ago
Theralase’s Rutherrin Activated by Diabetes Drug
PremiumCompany AnnouncementsTheralase’s Rutherrin Activated by Diabetes Drug
4M ago
Theralase Reports Decline in 2Q2024 Revenue
Premium
Company Announcements
Theralase Reports Decline in 2Q2024 Revenue
4M ago
Theralase Secures Funding to Advance Cancer Research
Premium
Company Announcements
Theralase Secures Funding to Advance Cancer Research
6M ago
Theralase Advances Cancer Treatment with Drug Repurposing
PremiumCompany Announcements
Theralase Advances Cancer Treatment with Drug Repurposing
6M ago
Theralase’s Drug Shows Promise Against Lung Cancer
PremiumCompany Announcements
Theralase’s Drug Shows Promise Against Lung Cancer
6M ago
Theralase Announces Upcoming Shareholder Meeting
PremiumCompany Announcements
Theralase Announces Upcoming Shareholder Meeting
6M ago
Theralase’s Rutherrin® Enhances Chemotherapy Success
PremiumCompany Announcements
Theralase’s Rutherrin® Enhances Chemotherapy Success
6M ago
Theralase’s Ruvidar Boosts Cancer Drug Efficacy
PremiumCompany AnnouncementsTheralase’s Ruvidar Boosts Cancer Drug Efficacy
7M ago
Theralase Achieves Breakthrough in Lung Cancer Treatment
Premium
Company Announcements
Theralase Achieves Breakthrough in Lung Cancer Treatment
7M ago
Theralase’s RuvidarTM Shows Multi-Virus Inactivation Potential
Premium
Company Announcements
Theralase’s RuvidarTM Shows Multi-Virus Inactivation Potential
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >